Florida

Showing 11-20 of 27 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D	University of Florida	Graciela Lorca	Cures	01-September-2019 to 31-August-2026	$355.941,78
Network for Pancreatic Organ Donors – nPOD	University of Florida	Mark Atkinson	Cures	01-October-2023 to 31-December-2026	$8.100.000,00
PRISE-hATG: Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset T1D Treated with Human Anti-Thymocyte Globulin	University of Florida	Michael Haller	Cures	01-July-2026 to 30-June-2030	$5.331.741,16
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2	University of Florida	Todd Brusko	Cures	01-September-2024 to 31-October-2026	$500.000,00
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement	University of Miami	Alice Tomei	Cures	01-February-2024 to 31-January-2027	$824.892,00
Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity	University of Miami	Dhanashree Surve	Cures	01-March-2026 to 28-February-2029	$274.010,00
The KQ1 serum study: amendment & extension	University of Miami	Dirk Homann	Cures	01-April-2025 to 31-October-2027	$1.723.254,07
Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas	University of Miami	Dirk Homann	Cures	01-April-2025 to 31-March-2027	$53.972,92
Safety, Feasibility, and Mechanistic Effects of Diroximel Fumarate (DRF) in New-Onset Type 1 Diabetes.	University of Miami	Francesco Vendrame	Cures	01-August-2026 to 31-July-2029	$698.164,00
Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration	University of Miami	Juan Dominguez-Bendala	Cures	01-April-2024 to 31-March-2027	$741.000,00